DB-OTO Gene Therapy for Inherited Deafness

Journal:

The New England Journal of Medicine

Published:

2025-10-13

DOI:

10.1056/nejmoa2400521

Affiliations:

19

Authors:

34

Go to article

Institutions	Authors	Share
Regeneron Pharmaceuticals, United States of America (USA)	18.500000 18.500000	0.54
University of Cambridge, United Kingdom (UK)	1.000000	0.03
University of California, San Diego (UC San Diego), United States of America (USA)	1.000000	0.03
University of California, Los Angeles (UCLA), United States of America (USA)	1.000000	0.03
Boston Children's Hospital (BCH), United States of America (USA)	1.000000	0.03
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA)	1.000000	0.03
Nemours Children's Hospital, United States of America (USA)	1.000000	0.03
UCL, United Kingdom (UK)	1.000000	0.03
University Hospital Tübingen (UKT), Uni Tübingen, Germany	1.000000	0.03
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.03
Hospital Universitario de Navarra (HUN), Spain	1.000000	0.03
Cincinnati Children's Hospital Medical Center (CCHMC), United States of America (USA)	1.000000	0.03
Hospital Universitario Ramón y Cajal, Spain	1.000000	0.03
Nemours Children's Health, Jacksonville, United States of America (USA)	1.000000	0.03
Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Spain	0.500000	0.01
Biomedical Research Networking Center on Rare Diseases (CIBERER), Spain	0.500000	0.01
Brigham and Women's Hospital (BWH), United States of America (USA)	0.500000	0.01
Seattle Children's Hospital, United States of America (USA)	0.500000	0.01
University of Washington (UW), United States of America (USA)	0.500000	0.01

Interested in Medical Biotechnology?